A case of ICIs-associated arthritis caused by Toripalimab initially presenting as oedema in both lower limbs
{{output}}
The use of immune checkpoint inhibitors (ICIs) has offered new hope for patients with malignant tumours; however, it is essential to acknowledge their potential toxic side effects. Among these, ICIs-associated arthritis (IA) is not uncommon but non-specific an... ...
